ADA Launches Pathway to Stop Diabetes
According to the Centers for Disease Control and Prevention, Diabetes is the number seven cause of death for Americans, killing some 71,000 patients annually. Almost 5,205 patients are diagnosed with the disease deadly, to spend the rest of their lives in treatment. This includes purchasing diabetic accessories ranging from insulin pump supplies to diabetes coolers, diabetes log books to insulin pen needles, cheap insulin syringes to the plenitude of testing kids and their associated accessories, such as test strips for accu-chek aviva, freestyle lancets, and true track strips. While it is certainly wonderful that supplies for diabetes are easy to acquire, and that the industry is competitive enough to allow for affordable prices, many diabetics would much prefer a cure for the chronic condition. Enter the American Diabetes Association’s Pathway to Stop Diabetes initiative.
Scientists and entrepreneurs alike are constantly working to come up with new solutions for managing, treating, and ultimately defeating diabetes—both type one and type two—and progress is rapid, to judge by the array of new technologies available on the market almost every month. Products such as insulin pen needles have already made administering insulin more convenient than previous generations of diabetics have known; even cheap insulin syringes are becoming more advanced, with finer, shorter needles for a more pain-free experience. Even in the case of blood-glucose testing, companies are developing newer technologies every day. Test strips for accu-chek aviva have become a popular diabetic accessory, along with freestyle lancets and true track strips, as meters are able to get definitive results from smaller samples of blood with greater accuracy. But the American Diabetes Association points out that this simply isn’t enough; ADA chair Dr. Karen Talmadge says of the disease, “Diabetes takes a staggering toll, personally, socially and economically,” adding that in spite of the seriousness of the disease, “Researchers are not choosing diabetes as their area of study. One reason is the level of funding.”
While Talmadge states that she would not ever ask the National Institutes of Health to devote less money to any of the serious diseases it provides grants to—such as cancer, a disease that affects 12.5 Americans compared to diabetes, which affects 25.8 million Americans; she does point out that research dollars “are very uneven,” and that diabetes research cannot develop at the pace that it should unless there is a larger budget for scientists. The ADA’s Pathway to Stop Diabetes will award $160 million over the next 10 years to 100 promising scientists looking to develop new treatments and even potentially seek cures. The ADA wants to initiate researchers and accelerate the work of those already targeting the disease; so while advances are made every day to improve products that diabetics already use, including insulin pump supplies, cheap insulin syringes, test strips for accu-chek aviva, freestyle lancets, and true track strips, along with the more recent insulin pen needles for administering medication, the ADA is still seeking more technologically advanced options and even potential cures, such as the pancreas replacement still in development, which could make diabetes a thing of the past.